ZERVIATE Drug Patent Profile
✉ Email this page to a colleague
When do Zerviate patents expire, and what generic alternatives are available?
Zerviate is a drug marketed by Harrow Eye and is included in one NDA. There are four patents protecting this drug.
This drug has twenty-three patent family members in seven countries.
The generic ingredient in ZERVIATE is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-six suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zerviate
A generic version of ZERVIATE was approved as cetirizine hydrochloride by PADAGIS US on June 17th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZERVIATE?
- What are the global sales for ZERVIATE?
- What is Average Wholesale Price for ZERVIATE?
Summary for ZERVIATE
International Patents: | 23 |
US Patents: | 4 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 119 |
Patent Applications: | 2,727 |
Drug Prices: | Drug price information for ZERVIATE |
What excipients (inactive ingredients) are in ZERVIATE? | ZERVIATE excipients list |
DailyMed Link: | ZERVIATE at DailyMed |


Pharmacology for ZERVIATE
Drug Class | Histamine-1 Receptor Antagonist |
Mechanism of Action | Histamine H1 Receptor Antagonists |
US Patents and Regulatory Information for ZERVIATE
ZERVIATE is protected by four US patents.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harrow Eye | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
Harrow Eye | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Harrow Eye | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Harrow Eye | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | Y | ⤷ Try for Free | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ZERVIATE
See the table below for patents covering ZERVIATE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2910374 | ⤷ Try for Free | |
Japan | 2020117544 | セチリジンの眼科用製剤および使用方法 (OPHTHALMOLOGIC PREPARATION OF CETIRIZINE AND METHODS OF USE) | ⤷ Try for Free |
European Patent Office | 2408453 | FORMULATIONS OPHTALMIQUES DE CÉTIRIZINE ET PROCÉDÉS D'UTILISATION (OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE) | ⤷ Try for Free |
Japan | 2015007136 | セチリジンの眼科用製剤および使用方法 (OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE) | ⤷ Try for Free |
World Intellectual Property Organization (WIPO) | 2011116020 | ⤷ Try for Free | |
Japan | 2016190879 | セチリジンの眼科用製剤および使用方法 (OPHTHALMOLOGIC PREPARATION OF CETIRIZINE AND METHODS OF USE) | ⤷ Try for Free |
World Intellectual Property Organization (WIPO) | 2010107689 | ⤷ Try for Free | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ZERVIATE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0663828 | C300085 | Netherlands | ⤷ Try for Free | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
0058146 | 2001C/045 | Belgium | ⤷ Try for Free | PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Market Dynamics and Financial Trajectory for ZERVIATE
More… ↓